Cargando…
Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells
BACKGROUND: Tumor glycolysis is a critical event for tumor progression. Docetaxel is widely used as a first-line drug for chemotherapy and shown to have a survival advantage. However, the role of docetaxel in tumor glycolysis remained poorly understood. METHODS: The effect of Docetaxel in tumor glyc...
Autores principales: | Peng, Junming, He, Zhijun, Yuan, Yeqing, Xie, Jing, Zhou, Yu, Guo, Baochun, Guo, Jinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762006/ https://www.ncbi.nlm.nih.gov/pubmed/36536346 http://dx.doi.org/10.1186/s12964-022-00950-z |
Ejemplares similares
-
MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein
por: Zhang, Heng, et al.
Publicado: (2016) -
SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells
por: Wang, Chunyang, et al.
Publicado: (2019) -
CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer
por: Wang, Yu-Zhao, et al.
Publicado: (2023) -
CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
por: Zhang, Yixiang, et al.
Publicado: (2020) -
MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis
por: Guo, Jinan, et al.
Publicado: (2019)